| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.704 | 0.006 | 0.704 | Spasmolytic | 0.652 0.009 DB00341 | ||
| 0.658 | 0.009 | 0.704 | Vasodilator, peripheral | 0.704 0.006 DB00341 | DB00341 | |
| 0.64 | 0.007 | 0.64 | Histamine release inhibitor | 0.543 0.017 DB00341 | ||
| 0.637 | 0.014 | 0.637 | Aldehyde oxidase inhibitor | 0.52 0.03 DB00341 | ||
| 0.613 | 0.025 | 0.613 | Analgesic | 0.57 0.033 DB00341 | ||
| 0.553 | 0.004 | 0.683 | Histamine H1 receptor antagonist | 0.683 0.003 DB00341 | DB00341 | |
| 0.507 | 0.004 | 0.507 | Nav1.3 sodium channel blocker | 0.303 0.009 DB00341 | ||
| 0.474 | 0.019 | 0.49 | Vasodilator, coronary | 0.49 0.017 DB00341 | DB00341 | |
| 0.441 | 0.005 | 0.441 | Antihistaminic | 0.441 0.005 DB00341 | ||
| 0.415 | 0.005 | 0.42 | Histamine antagonist | 0.42 0.005 DB00341 | DB00341 | |
| 0.431 | 0.024 | 0.431 | Cardiotonic | 0.404 0.028 DB00341 | ||
| 0.407 | 0.004 | 0.407 | Nav1.1 sodium channel blocker | 0.369 0.005 DB00341 | ||
| 0.404 | 0.005 | 0.546 | Mediator release inhibitor | 0.546 0.004 DB00341 | DB00341 | |
| 0.386 | 0.007 | 0.401 | Antipruritic | 0.401 0.006 DB00341 | DB00341 | |
| 0.378 | 0.012 | 0.383 | Phospholipase C inhibitor | 0.383 0.012 DB00341 | DB00341 | |
| 0.367 | 0.004 | 0.367 | Ca(v)2.2 blocker | 0.322 0.005 DB00341 | ||
| 0.413 | 0.052 | 0.413 | Thioredoxin glutathione reductase inhibitor | 0.399 0.058 DB00341 | ||
| 0.359 | 0.006 | 0.359 | Calcium channel blocker | 0.294 0.01 DB00341 | ||
| 0.366 | 0.029 | 0.374 | Vasodilator | 0.374 0.028 DB00341 | DB00341 | |
| 0.354 | 0.029 | 0.378 | Anticonvulsant | 0.378 0.025 DB00341 | DB00341 | |
| 0.335 | 0.01 | 0.335 | Anesthetic local | 0.255 0.019 DB00341 | ||
| 0.326 | 0.012 | 0.326 | Nav1.2 sodium channel blocker | 0.293 0.016 DB00341 | ||
| 0.302 | 0.005 | 0.302 | Calcium antagonist | 0.295 0.005 DB00341 | ||
| 0.291 | 0.023 | 0.291 | Neuropeptide Y2 antagonist | 0.247 0.059 DB00341 | ||
| 0.284 | 0.017 | 0.284 | Acetylcholine M1 receptor antagonist | 0.219 0.035 DB00341 | ||
| 0.354 | 0.111 | 0.354 | 5 Hydroxytryptamine release inhibitor | 0.306 0.158 DB00341 | ||
| 0.259 | 0.019 | 0.259 | NADPH oxidase inhibitor | 0.139 0.063 DB00341 | ||
| 0.313 | 0.083 | 0.365 | Cholesterol antagonist | 0.365 0.058 DB00341 | DB00341 | |
| 0.271 | 0.042 | 0.271 | Anesthetic general | 0.159 0.104 DB00341 | ||
| 0.326 | 0.1 | 0.38 | Antiobesity | 0.38 0.074 DB00341 | DB00341 | |
| 0.228 | 0.006 | 0.228 | Multidrug resistance-associated protein 1 inhibitor | 0.184 0.014 DB00341 | ||
| 0.306 | 0.086 | 0.306 | Calcium channel activator | 0.3 0.092 DB00341 | ||
| 0.225 | 0.005 | 0.225 | Calcium channel L-type blocker | 0.184 0.006 DB00341 | ||
| 0.235 | 0.018 | 0.253 | ATPase inhibitor | 0.253 0.013 DB00341 | DB00341 | |
| 0.228 | 0.012 | 0.228 | Calcium channel (voltage-sensitive) blocker | 0.187 0.02 DB00341 | ||
| 0.298 | 0.087 | 0.369 | Apoptosis antagonist | 0.369 0.048 DB00341 | DB00341 | |
| 0.227 | 0.017 | 0.227 | Neurotrophic factor | 0.212 0.023 DB00341 | ||
| 0.215 | 0.007 | 0.215 | Cannabinoid receptor antagonist | 0.106 0.026 DB00341 | ||
| 0.248 | 0.049 | 0.248 | Sigma receptor agonist | 0.206 0.06 DB00341 | ||
| 0.201 | 0.005 | 0.201 | Cannabinoid CB1 receptor antagonist | 0.103 0.015 DB00341 | ||
| 0.259 | 0.072 | 0.288 | Interleukin agonist | 0.288 0.054 DB00341 | DB00341 | |
| 0.219 | 0.036 | 0.334 | Succinate dehydrogenase inhibitor | 0.334 0.007 DB00341 | DB00341 | |
| 0.185 | 0.005 | 0.185 | Ca2+-transporting ATPase inhibitor | 0.185 0.005 DB00341 | ||
| 0.183 | 0.007 | 0.183 | Dopamine uptake inhibitor | 0.127 0.013 DB00341 | ||
| 0.212 | 0.037 | 0.296 | Phospholipase A2 inhibitor | 0.296 0.014 DB00341 | DB00341 | |
| 0.275 | 0.107 | 0.444 | Antithrombotic | 0.444 0.039 DB00341 | DB00341 | |
| 0.191 | 0.023 | 0.191 | Nav1.6 sodium channel blocker | 0.157 0.046 DB00341 | ||
| 0.175 | 0.01 | 0.222 | Macrophage migration inhibitory factor inhibitor | 0.222 0.006 DB00341 | DB00341 | |
| 0.185 | 0.027 | 0.185 | Alpha 2b adrenoreceptor antagonist | |||
| 0.164 | 0.008 | 0.164 | Lanosterol 14 alpha demethylase inhibitor | 0.145 0.013 DB00341 | ||
| 0.157 | 0.002 | 0.163 | GABA uptake inhibitor | 0.163 0.002 DB00341 | DB00341 | |
| 0.165 | 0.012 | 0.165 | Analgesic, opioid | 0.149 0.015 DB00341 | ||
| 0.161 | 0.011 | 0.161 | Acetylcholine release stimulant | 0.112 0.062 DB00341 | ||
| 0.177 | 0.03 | 0.177 | Antibacterial (Helicobacter pylori) | 0.172 0.032 DB00341 | ||
| 0.207 | 0.065 | 0.263 | Non-steroidal antiinflammatory agent | 0.263 0.038 DB00341 | DB00341 | |
| 0.2 | 0.062 | 0.2 | 5 Hydroxytryptamine 3E antagonist | 0.176 0.116 DB00341 | ||
| 0.165 | 0.026 | 0.165 | Alpha 2c adrenoreceptor antagonist | 0.096 0.07 DB00341 | ||
| 0.169 | 0.034 | 0.188 | Cyclooxygenase 3 inhibitor | 0.188 0.023 DB00341 | DB00341 | |
| 0.169 | 0.034 | 0.169 | Acetylcholine muscarinic antagonist | 0.125 0.063 DB00341 | ||
| 0.141 | 0.009 | 0.141 | Acetylcholine M5 receptor antagonist | 0.068 0.032 DB00341 | ||
| 0.319 | 0.188 | 0.319 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.289 0.228 DB00341 | ||
| 0.213 | 0.082 | 0.217 | RNA-directed DNA polymerase inhibitor | 0.217 0.078 DB00341 | DB00341 | |
| 0.2 | 0.073 | 0.278 | Insulin sensitizer | 0.278 0.022 DB00341 | DB00341 | |
| 0.179 | 0.052 | 0.179 | Amylase inhibitor | |||
| 0.159 | 0.032 | 0.159 | Calcium channel N-type blocker | 0.141 0.043 DB00341 | ||
| 0.16 | 0.037 | 0.16 | 5 Hydroxytryptamine 2B antagonist | 0.1 0.084 DB00341 | ||
| 0.132 | 0.018 | 0.132 | Dopamine agonist | 0.078 0.038 DB00341 | ||
| 0.154 | 0.043 | 0.154 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.164 | 0.059 | 0.164 | Lipid peroxidase inhibitor | 0.146 0.071 DB00341 | ||
| 0.122 | 0.017 | 0.122 | Acetylcholine M4 receptor antagonist | 0.076 0.05 DB00341 | ||
| 0.154 | 0.05 | 0.154 | Cholinergic antagonist | 0.102 0.093 DB00341 | ||
| 0.111 | 0.009 | 0.111 | Phospholipase D inhibitor | 0.081 0.033 DB00341 | ||
| 0.107 | 0.005 | 0.107 | Calcium channel P-type blocker | 0.087 0.01 DB00341 | ||
| 0.132 | 0.033 | 0.132 | Creatine kinase inhibitor | 0.124 0.038 DB00341 | ||
| 0.152 | 0.054 | 0.194 | Alpha-N-acetylglucosaminidase inhibitor | 0.194 0.036 DB00341 | DB00341 | |
| 0.179 | 0.081 | 0.179 | P-glycoprotein inhibitor | 0.162 0.099 DB00341 | ||
| 0.103 | 0.006 | 0.111 | MDM2 inhibitor | 0.111 0.005 DB00341 | DB00341 | |
| 0.118 | 0.026 | 0.118 | Opioid delta receptor antagonist | 0.114 0.027 DB00341 | ||
| 0.143 | 0.054 | 0.143 | Acetylcholine antagonist | |||
| 0.104 | 0.015 | 0.111 | Calcium channel T-type blocker | 0.111 0.013 DB00341 | DB00341 | |
| 0.106 | 0.017 | 0.106 | Acetylcholine M5 receptor agonist | |||
| 0.122 | 0.035 | 0.122 | Opioid antagonist | 0.112 0.04 DB00341 | ||
| 0.1 | 0.014 | 0.1 | Dopamine D4 agonist | 0.069 0.023 DB00341 | ||
| 0.114 | 0.031 | 0.114 | Alpha 1b adrenoreceptor antagonist | |||
| 0.111 | 0.029 | 0.111 | Bromodomain-containing protein 2 inhibitor | |||
| 0.212 | 0.13 | 0.235 | 5 Hydroxytryptamine uptake stimulant | 0.235 0.097 DB00341 | DB00341 | |
| 0.104 | 0.024 | 0.104 | Dopamine D1 antagonist | 0.059 0.051 DB00341 | ||
| 0.239 | 0.159 | 0.334 | Toll-Like receptor agonist | 0.334 0.091 DB00341 | DB00341 | |
| 0.236 | 0.16 | 0.34 | Toll-Like receptor 7 agonist | 0.34 0.087 DB00341 | DB00341 | |
| 0.115 | 0.039 | 0.115 | MAP kinase kinase 1 inhibitor | |||
| 0.127 | 0.051 | 0.127 | GABA receptor agonist | |||
| 0.13 | 0.055 | 0.13 | Sphingosine 1-phosphate receptor 4 antagonist | 0.111 0.091 DB00341 | ||
| 0.087 | 0.015 | 0.087 | Dopamine transporter inhibitor | 0.065 0.022 DB00341 | ||
| 0.237 | 0.166 | 0.251 | GABA C receptor rho-3 antagonist | 0.251 0.153 DB00341 | DB00341 | |
| 0.087 | 0.016 | 0.087 | Opioid agonist | 0.078 0.02 DB00341 | ||
| 0.062 | 0.004 | 0.062 | Ceramide glucosyltransferase inhibitor | 0.042 0.014 DB00341 | ||
| 0.163 | 0.105 | 0.163 | Psychostimulant | 0.147 0.119 DB00341 | ||
| 0.131 | 0.073 | 0.131 | Sodium channel blocker | |||
| 0.107 | 0.052 | 0.107 | Sphingomyelinase inhibitor | |||
| 0.116 | 0.06 | 0.116 | Nav1.5 sodium channel blocker | 0.098 0.089 DB00341 | ||
| 0.12 | 0.065 | 0.124 | Cholesterol synthesis inhibitor | 0.124 0.061 DB00341 | DB00341 | |
| 0.106 | 0.052 | 0.106 | Antiadrenergic | |||
| 0.089 | 0.035 | 0.089 | Viral attachment inhibitor | |||
| 0.082 | 0.028 | 0.101 | Carbamoyl phosphate synthetase inhibitor | 0.101 0.02 DB00341 | DB00341 | |
| 0.094 | 0.041 | 0.094 | Dopamine antagonist | |||
| 0.104 | 0.051 | 0.104 | Adrenaline antagonist | |||
| 0.08 | 0.028 | 0.08 | Cannabinoid CB1 receptor agonist | |||
| 0.096 | 0.045 | 0.096 | Alpha 1 adrenoreceptor antagonist | |||
| 0.098 | 0.048 | 0.098 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.083 | 0.033 | 0.083 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.055 | 0.005 | 0.055 | Nociceptin (N/OFQ) receptor agonist | 0.041 0.007 DB00341 | ||
| 0.077 | 0.027 | 0.082 | NMDA 2C receptor antagonist | 0.082 0.024 DB00341 | DB00341 | |
| 0.086 | 0.037 | 0.086 | Dopamine D2 antagonist | |||
| 0.09 | 0.042 | 0.09 | Alpha 2a adrenoreceptor antagonist | |||
| 0.072 | 0.024 | 0.072 | Potassium channel intermediate-conductance Ca-activated blocker | 0.065 0.033 DB00341 | ||
| 0.164 | 0.116 | 0.164 | HERG channel blocker | |||
| 0.09 | 0.045 | 0.09 | Opioid kappa receptor antagonist | 0.088 0.048 DB00341 | ||
| 0.182 | 0.138 | 0.195 | Superoxide dismutase inhibitor | 0.195 0.123 DB00341 | DB00341 | |
| 0.087 | 0.043 | 0.087 | Ca(v)3.1 blocker | 0.082 0.055 DB00341 | ||
| 0.182 | 0.138 | 0.182 | 5 Hydroxytryptamine release stimulant | |||
| 0.163 | 0.12 | 0.163 | Neurotrophic factor enhancer | 0.156 0.129 DB00341 | ||
| 0.093 | 0.051 | 0.093 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.064 | 0.022 | 0.064 | Alpha-mannosidase inhibitor | 0.054 0.036 DB00341 | ||
| 0.085 | 0.044 | 0.085 | Interferon agonist | |||
| 0.113 | 0.073 | 0.113 | Adenylate cyclase inhibitor | |||
| 0.073 | 0.033 | 0.073 | Alpha 1d adrenoreceptor antagonist | |||
| 0.162 | 0.123 | 0.162 | Potassium channel blocker | |||
| 0.048 | 0.01 | 0.073 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.073 0.005 DB00341 | DB00341 | |
| 0.071 | 0.034 | 0.071 | Interferon inducer | |||
| 0.091 | 0.054 | 0.097 | NADH dehydrogenase inhibitor | 0.097 0.047 DB00341 | DB00341 | |
| 0.096 | 0.059 | 0.096 | Alpha adrenoreceptor antagonist | |||
| 0.158 | 0.122 | 0.158 | MAP kinase kinase 5 inhibitor | |||
| 0.184 | 0.148 | 0.184 | DNA synthesis inhibitor | |||
| 0.061 | 0.025 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.156 | 0.122 | 0.373 | Platelet aggregation inhibitor | 0.373 0.022 DB00341 | DB00341 | |
| 0.125 | 0.092 | 0.125 | Mannose-6-phosphate isomerase inhibitor | 0.125 0.092 DB00341 | ||
| 0.051 | 0.018 | 0.051 | Thymidine kinase inhibitor | |||
| 0.087 | 0.058 | 0.087 | Alpha 2 adrenoreceptor antagonist | |||
| 0.056 | 0.027 | 0.056 | Potassium channel (Inward rectifier) blocker | |||
| 0.047 | 0.018 | 0.047 | Heme oxygenase inhibitor | 0.045 0.022 DB00341 | ||
| 0.044 | 0.016 | 0.044 | Opioid delta receptor agonist | 0.042 0.018 DB00341 | ||
| 0.128 | 0.101 | 0.128 | Heat shock protein 90 antagonist | |||
| 0.043 | 0.018 | 0.043 | p53 inhibitor | 0.042 0.019 DB00341 | ||
| 0.065 | 0.04 | 0.065 | Dopamine D3 antagonist | |||
| 0.144 | 0.12 | 0.144 | Catenin beta inhibitor | |||
| 0.126 | 0.102 | 0.174 | Insulin secretagoues | 0.174 0.052 DB00341 | DB00341 | |
| 0.089 | 0.067 | 0.118 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.118 0.04 DB00341 | DB00341 | |
| 0.072 | 0.05 | 0.072 | Alpha 1a adrenoreceptor antagonist | |||
| 0.049 | 0.027 | 0.049 | Mannosidase inhibitor | |||
| 0.056 | 0.034 | 0.078 | Thromboxane synthase inhibitor | 0.078 0.013 DB00341 | DB00341 | |
| 0.056 | 0.035 | 0.056 | Epithelial sodium channel blocker | |||
| 0.068 | 0.048 | 0.068 | Phenylalanine 4-hydroxylase inhibitor | 0.061 0.057 DB00341 | ||
| 0.037 | 0.017 | 0.037 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.023 DB00341 | ||
| 0.187 | 0.168 | 0.252 | Hypoxia-inducible factor 1 alpha inhibitor | 0.252 0.099 DB00341 | DB00341 | |
| 0.051 | 0.035 | 0.051 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.056 | 0.041 | 0.056 | Pregnane X receptor antagonist | 0.054 0.049 DB00341 | ||
| 0.03 | 0.015 | 0.03 | DNA polymerase III inhibitor | |||
| 0.072 | 0.058 | 0.072 | Potassium channel (Tandem pore domain) blocker | |||
| 0.025 | 0.013 | 0.025 | Phosphodiesterase 6A inhibitor | |||
| 0.114 | 0.103 | 0.121 | Vanilloid 1 agonist | 0.121 0.085 DB00341 | DB00341 | |
| 0.048 | 0.036 | 0.048 | CC chemokine receptor 2B antagonist | 0.045 0.041 DB00341 | ||
| 0.039 | 0.028 | 0.039 | Dopamine D3 agonist | |||
| 0.056 | 0.046 | 0.056 | Acetylcholine M3 receptor antagonist | |||
| 0.182 | 0.172 | 0.227 | Tyrosine 3 hydroxylase inhibitor | 0.227 0.093 DB00341 | DB00341 | |
| 0.087 | 0.077 | 0.087 | Bronchodilator | |||
| 0.059 | 0.05 | 0.059 | 5 Hydroxytryptamine 3 agonist | |||
| 0.027 | 0.018 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.039 | 0.031 | 0.039 | CC chemokine 3 receptor antagonist | |||
| 0.191 | 0.184 | 0.191 | Caspase 3 stimulant | |||
| 0.125 | 0.119 | 0.183 | Arachidonic acid antagonist | 0.183 0.05 DB00341 | DB00341 | |
| 0.054 | 0.048 | 0.064 | Leukotriene C antagonist | 0.064 0.021 DB00341 | DB00341 | |
| 0.027 | 0.022 | 0.027 | Estrogen-related receptor gamma antagonist | |||
| 0.034 | 0.029 | 0.045 | Glutamate (mGluR8) antagonist | 0.045 0.012 DB00341 | DB00341 | |
| 0.056 | 0.052 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.059 | 0.055 | 0.059 | Opioid mu receptor antagonist | |||
| 0.101 | 0.097 | 0.101 | Estrogen antagonist | |||
| 0.113 | 0.11 | 0.158 | Cell wall synthesis inhibitor | 0.158 0.058 DB00341 | DB00341 | |
| 0.013 | 0.01 | 0.013 | DNA polymerase III polC-type inhibitor | |||
| 0.007 | 0.005 | 0.007 | DNA polymerase III subunit alpha inhibitor | |||
| 0.03 | 0.028 | 0.03 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.024 | 0.023 | 0.024 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.243 | 0.242 | 0.243 | MAP kinase 1 inhibitor | |||
| 0.042 | 0.044 | 0.087 | Thromboxane A2 antagonist | 0.087 0.011 DB00341 | DB00341 | |
| 0.044 | 0.049 | 0.095 | Thromboxane antagonist | 0.095 0.013 DB00341 | DB00341 | |
| 0.016 | 0.022 | 0.03 | Prostaglandin EP2 agonist | 0.03 0.012 DB00341 | DB00341 | |
| 0.157 | 0.167 | 0.238 | Hypoglycemic | 0.238 0.084 DB00341 | DB00341 | |
| 0.026 | 0.042 | 0.041 | Carnitine palmitoyltransferase 1 inhibitor | 0.041 0.015 DB00341 | DB00341 | |
| 0.14 | 0.157 | 0.446 | Platelet antagonist | 0.446 0.02 DB00341 | DB00341 | |
| 0.073 | 0.091 | 0.107 | Triose-phosphate isomerase inhibitor | 0.107 0.041 DB00341 | DB00341 | |
| 0.033 | 0.051 | 0.054 | Glycine transporter inhibitor | 0.054 0.028 DB00341 | DB00341 | |
| 0.025 | 0.045 | 0.04 | Carnitine palmitoyltransferase inhibitor | 0.04 0.015 DB00341 | DB00341 | |
| 0.104 | 0.128 | 0.158 | Diuretic | 0.158 0.071 DB00341 | DB00341 | |
| 0.034 | 0.061 | 0.049 | Glutamate (mGluR4) antagonist | 0.049 0.022 DB00341 | DB00341 | |
| 0.019 | 0.047 | 0.032 | Prostaglandin agonist | 0.032 0.019 DB00341 | DB00341 | |
| 0.012 | 0.041 | 0.023 | Prostaglandin E2 agonist | 0.023 0.016 DB00341 | DB00341 | |
| 0.135 | 0.169 | 0.177 | Immunostimulant | 0.177 0.135 DB00341 | DB00341 | |
| 0.062 | 0.096 | 0.115 | NMDA receptor antagonist | 0.115 0.038 DB00341 | DB00341 | |
| 0.076 | 0.114 | 0.15 | Cystathionine beta-synthase inhibitor | 0.15 0.041 DB00341 | DB00341 | |
| 0.008 | 0.053 | 0.016 | Thromboxane A2 agonist | 0.016 0.01 DB00341 | DB00341 | |
| 0.014 | 0.068 | 0.049 | Leukotriene A4 hydrolase inhibitor | 0.049 0.021 DB00341 | DB00341 | |
| 0.051 | 0.109 | 0.066 | Glutamate (mGluR6) antagonist | 0.066 0.049 DB00341 | DB00341 | |
| 0.007 | 0.067 | 0.031 | Prostaglandin H2 antagonist | 0.031 0.013 DB00341 | DB00341 | |
| 0.174 | 0.24 | 0.225 | Interleukin 2 agonist | 0.225 0.149 DB00341 | DB00341 | |
| 0.029 | 0.107 | 0.062 | NMDA receptor glycine site agonist | 0.062 0.043 DB00341 | DB00341 | |
| 0.138 | 0.219 | 0.222 | Lipoxygenase inhibitor | 0.222 0.12 DB00341 | DB00341 | |
| 0.071 | 0.153 | 0.097 | Glutamate (mGluR7) agonist | 0.097 0.065 DB00341 | DB00341 | |
| 0.028 | 0.124 | 0.051 | Leukotriene B4 antagonist | 0.051 0.043 DB00341 | DB00341 | |
| 0.031 | 0.128 | 0.071 | Leukotriene antagonist | 0.071 0.039 DB00341 | DB00341 | |
| 0.14 | 0.238 | 0.189 | Gastrin inhibitor | 0.189 0.166 DB00341 | DB00341 | |
| 0.101 | 0.207 | 0.184 | Hypolipemic | 0.184 0.106 DB00341 | DB00341 | |
| 0.005 | 0.118 | 0.095 | Prostacyclin agonist | 0.095 0.003 DB00341 | DB00341 | |
| 0.058 | 0.182 | 0.096 | Electrolyte absorption antagonist | 0.096 0.064 DB00341 | DB00341 | |
| 0.026 | 0.175 | 0.081 | Leukotriene synthesis inhibitor | 0.081 0.037 DB00341 | DB00341 | |
| 0.009 | 0.16 | 0.068 | Prostaglandin D2 agonist | 0.068 0.004 DB00341 | DB00341 | |
| 0.045 | 0.204 | 0.087 | Cell adhesion molecule inhibitor | 0.087 0.046 DB00341 | DB00341 | |
| 0.166 | 0.33 | 0.392 | Cyclophilin D inhibitor | 0.392 0.096 DB00341 | DB00341 | |
| 0.063 | 0.229 | 0.136 | Cell adhesion inhibitor | 0.136 0.055 DB00341 | DB00341 | |
| 0.012 | 0.226 | 0.127 | Prostaglandin antagonist | 0.127 0.013 DB00341 | DB00341 | |
| 0.004 | 0.239 | 0.045 | Prostaglandin D2 antagonist | 0.045 0.007 DB00341 | DB00341 | |
| 0.005 | 0.284 | 0.055 | Prostacyclin antagonist | 0.055 0.011 DB00341 | DB00341 | |
| 0.022 | 0.43 | 0.164 | Protein-tyrosine phosphatase inhibitor | 0.164 0.066 DB00341 | DB00341 | |
| 0.009 | 0.443 | 0.104 | Protein-tyrosine phosphatase 1B inhibitor | 0.104 0.074 DB00341 | DB00341 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |